Delcath Systems, Inc. (DCTH) is a cutting-edge medical device company dedicated to improving treatment options for patients with liver cancer and other conditions involving the liver. The company specializes in creating unique medical technologies that deliver high-dose chemotherapy directly to the liver while minimizing exposure to the rest of the body. At the core of […]
Read MoreAligos Therapeutics, Inc. (ALGS) is a biopharmaceutical company dedicated to developing targeted therapies for viral and liver diseases. Their focus lies in addressing unmet medical needs, particularly in hepatitis B and non-alcoholic steatohepatitis (NASH). The company uses its proprietary technology platforms to create precision treatments that aim to improve patient outcomes significantly. Aligos’ core products […]
Read MoreFeatured Content Travere Therapeutics, Inc. (TVTX) is a biopharmaceutical company focused on developing and delivering therapies for rare and underserved diseases. Travere’s mission centers on advancing treatments for patients with serious and often overlooked conditions, primarily in the areas of nephrology (kidney diseases) and hepatology (liver diseases). The company’s pipeline includes innovative therapies aimed at […]
Read More